Micron Biomedical

News & Press Releases

In The News

Reuters Spotlights Micron’s Progress Toward Mass Production of Its Proprietary Microarray Technology

November 16, 2023

FiercePharma Spotlights Micron Biomedical’s Progress to Commercializing a Life-Saving “Button”

November 16, 2023

Atlanta News First Spotlights Micron Biomedical’s “Game Changing Technology”

November 16, 2023

Micron Biomedical CEO to Speak at Reuters Signature Event in a Health Equity Fireside Chat

November 14, 2023

Impact and Cost-Effectiveness of Microarray Technology Featured in BMJ Journal

November 8, 2023

Micron Joins Global Life Science Industry Leaders at BioEurope

November 6, 2023

Press Releases

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023

Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors

August 9, 2023

Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children

May 17, 2023

Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market

May 10, 2023

Micron Biomedical Secures Series A Financing to Commercialize MAP Technology for Self-Administration of Drugs and Vaccines without Needles

November 28, 2022

Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines

July 26, 2022